Career Development Program
Career Development Program
批准号:
8738877
负责人:
JAMES A FAGIN
金额:
$6.36万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-19 至 2019-08-31
关键词:
AttentionBasic ScienceCancer BiologyCareer ChoiceClinicalClinical InvestigatorClinical OncologyClinical SciencesClinical TrialsComplementContinuity of Patient CareDevelopmentDisciplineDiscipline of Nuclear MedicineDiseaseDisease ManagementDisease OutcomeDoctor of PhilosophyEndocrinologistEnvironmentFacultyFundingGeneticGoalsGrantGrowthHead and neck structureHome environmentHospitalsHumanIncidenceInstitutesInstitutionInvestigationLaboratoriesLeadLeadershipLinkMalignant NeoplasmsMalignant neoplasm of thyroidMedicineMemorial Sloan-Kettering Cancer CenterMentorsMentorshipModalityModelingMonitorOperative Surgical ProceduresPathogenesisPathway interactionsPatientsPhysiciansPlayPostdoctoral FellowProcessRadioactive IodineRecruitment ActivityRefractoryRefractory DiseaseResearchResearch InfrastructureResearch PersonnelResearch TrainingSECTM1 geneSchoolsScienceScientistSiteSourceStudentsSurgeonTalentsTherapeuticThyroid GlandThyroid HormonesThyroid carcinomaTimeTrainingTraining ProgramsTraining and EducationTranslational ResearchUnited States National Institutes of HealthWorkadvanced diseaseanticancer researchcancer geneticscareercareer developmentchemotherapeutic agentclinical applicationeffective therapyimprovedinterestinvestigator trainingmemberoncologyoutcome forecastpost-doctoral trainingprogramsprospectivetherapeutic targettrend
中文摘要
SPORE职业发展计划(CDP)将为独立的医生和科学家做好准备。
在甲状腺癌转化研究的职业生涯。我们的目标是,调查人员通过这一点资助
过程将花费他们的职业生涯进行甲状腺癌的转化研究,
成为该领域的知识领袖。纪念斯隆-凯特琳癌症中心(MSKCC)非常适合
对于这项任务,由于我们的主校区和附属机构的科学和临床环境,
以及我们培养最高质量的医生和科学家的悠久传统。我们的体制环境
包括许多NIH培训赠款,包括K12转化科学培训,T32培训补助金,
肿瘤学转化研究博士,临床研究证书课程,与
威尔康奈尔大学的临床和转化科学课程,以及一个完善的初级教师指导
程序.我们计划在未来5年内使用SPORE职业发展基金,
现有的正式培训计划,并挖掘学生的才能入学和毕业,
格斯特纳斯隆-凯特琳生物医学研究生院。我们将鼓励更多的医生
培训人员专注于甲状腺癌的转化研究,并努力吸引基础科学家,
有兴趣将他们的博士后训练投入到有现实潜力的发现中,
临床应用。MSKCC甲状腺孢子职业发展计划的具体目标是
1)支持高级博士后研究员的教育,培训和研究,以从事以下工作:
甲状腺癌的转化研究,使用双重临床和实验室导师模式。这个目标,
整合但不直接由SPORE资助,将导致目标2的候选人。2)招募和指导
初级教师在甲状腺癌的转化研究工作。职业发展委员会,共同主持
詹姆斯·费金博士和大卫·菲斯特博士将指导职业发展计划。的
委员会将包括来自临床和基础科学的代表。
英文摘要
The SPORE Career Development Program (CDP) will prepare physicians and scientists for independent
careers in translational research in thyroid cancer. Our goal is that the investigators funded through this
process will spend their professional lifetimes conducting translational research in thyroid cancer, and
become intellectual leaders in the field. Memorial Sloan-Kettering Cancer Center (MSKCC) is ideally suited
for this task, because of the scientific and clinical environment at our main campus and affiliated institutions,
and our long tradition of training physicians and scientists of the highest quality. Our institutional environment
includes numerous NIH training grants, including a K12 for translational science training, a T32 grant to train
PhDs in translational research in oncology, a Certificate Program in Clinical Investigation integrated with the
Clinical and Translational Science Program at Weill Cornell, and a well established junior faculty mentoring
program. We plan to use the SPORE Career Development funds over the next 5 years to enhance the
existing formal training programs and tap into the talent of students matriculating and graduating from the
Gerstner Sloan-Kettering Graduate School for Biomedical Sciences. We will encourage more physician
trainees to focus on translational research in thyroid cancer and strive to attract basic scientists who are
interested in devoting their postdoctoral training to making discoveries that have a realistic potential to lead
to clinical applications. The specific aims of the MSKCC Thyroid SPORE Career Development Program are
to: 1) To support the education, training and research of advanced postdoctoral fellows for careers in
translational research in thyroid cancer, using a dual clinical and laboratory mentorship model. This aim,
integrated but not directly funded by the SPORE, will lead to candidates for aim 2. 2) To recruit and mentor
junior faculty to work in translational research in thyroid cancer. A Career Development Committee, cochaired
by Dr. James Fagin and Dr. David Pfister, will direct the Career Development Program. The
Committee will include representatives from both clinical and basic sciences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting immune suppressive microenvironment in ATC
-
批准号:10559692
-
项目类别:
-
资助金额:$43.19万
-
财政年份:2021
-
负责人:JAMES A FAGIN
-
依托单位:
Improving efficacy of radioiodine treatment of thyroid cancer
-
批准号:10375547
-
项目类别:
-
资助金额:$46.2万
-
财政年份:2021
-
负责人:JAMES A FAGIN
-
依托单位:
Improving efficacy of radioiodine treatment of thyroid cancer
-
批准号:10211728
-
项目类别:
-
资助金额:$47.14万
-
财政年份:2021
-
负责人:JAMES A FAGIN
-
依托单位:
Targeting immune suppressive microenvironment in ATC
-
批准号:10333316
-
项目类别:
-
资助金额:$43.19万
-
财政年份:2021
-
负责人:JAMES A FAGIN
-
依托单位:
Improving efficacy of radioiodine treatment of thyroid cancer
-
批准号:10595560
-
项目类别:
-
资助金额:$46.2万
-
财政年份:2021
-
负责人:JAMES A FAGIN
-
依托单位:
Head and Neck Training Program in Surgical Oncology
-
批准号:10166773
-
项目类别:
-
资助金额:$16.39万
-
财政年份:2019
-
负责人:JAMES A FAGIN
-
依托单位:
Head and Neck Training Program in Surgical Oncology
-
批准号:10429955
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2019
-
负责人:JAMES A FAGIN
-
依托单位:
Maximizing Effectiveness of Radioiodine Therapy by Inhibiting MAPK Signaling
-
批准号:8738870
-
项目类别:
-
资助金额:$33.02万
-
财政年份:2014
-
负责人:JAMES A FAGIN
-
依托单位:
SPORE in Thyroid Cancer
-
批准号:8738868
-
项目类别:
-
资助金额:$200.85万
-
财政年份:2014
-
负责人:JAMES A FAGIN
-
依托单位:
Developmental Research Program
-
批准号:8738876
-
项目类别:
-
资助金额:$6.36万
-
财政年份:2014
-
负责人:JAMES A FAGIN
-
依托单位:
Maximizing effectiveness of radioiodine therapy by inhibition of MAPK signaling
-
批准号:8692698
-
项目类别:
-
资助金额:$40.21万
-
财政年份:2013
-
负责人:JAMES A FAGIN
-
依托单位:
Maximizing effectiveness of radioiodine therapy by inhibition of MAPK signaling
-
批准号:8578795
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2013
-
负责人:JAMES A FAGIN
-
依托单位:
N-acetylcysteine as a Potential Treatment for Methamphetamine Dependence
-
批准号:6337907
-
项目类别:
-
资助金额:$39.1万
-
财政年份:2009
-
负责人:JAMES A FAGIN
-
依托单位:
A Validated Resource of Thyroid Cancer Cell Lines for Pathway Discovery
-
批准号:7842829
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:JAMES A FAGIN
-
依托单位:
A Validated Resource of Thyroid Cancer Cell Lines for Pathway Discovery
-
批准号:7943960
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2009
-
负责人:JAMES A FAGIN
-
依托单位:
PARACRINE IGF/IGFBP INTERACTIONS IN VIVO
-
批准号:6517489
-
项目类别:
-
资助金额:$28.29万
-
财政年份:1998
-
负责人:JAMES A FAGIN
-
依托单位:
PARACRINE IGF/IGFBP INTERACTIONS IN VIVO
-
批准号:2669535
-
项目类别:
-
资助金额:$27.26万
-
财政年份:1998
-
负责人:JAMES A FAGIN
-
依托单位:
Paracrine IGF/GFBP Interactions In Vivo
-
批准号:6754520
-
项目类别:
-
资助金额:$35.64万
-
财政年份:1998
-
负责人:JAMES A FAGIN
-
依托单位:
Paracrine IGF/GFBP Interactions In Vivo
-
批准号:7059998
-
项目类别:
-
资助金额:$15.53万
-
财政年份:1998
-
负责人:JAMES A FAGIN
-
依托单位:
PARACRINE IGF/IGFBP INTERACTIONS IN VIVO
-
批准号:6178070
-
项目类别:
-
资助金额:$27.08万
-
财政年份:1998
-
负责人:JAMES A FAGIN
-
依托单位:
海外基金